Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil

References

• Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016;30:179–206. doi: 10.1016/j.idc.2015.10.006
   PubMed Web of Science ®Google Scholar
• Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis. 2010;50:1101–1111. doi: 10.1086/651262
   PubMed Web of Science ®Google Scholar
• Ponzio V, Camargo LF, Medina-Pestana J, et al. Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system. Transplant Infect Dis. 2018;20:e12910. doi: 10.1111/tid.12910
   PubMed Web of Science ®Google Scholar
• BaddleyJW, Forrest GN, AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):242–249.
   PubMed Web of Science ®Google Scholar
• Yang YL, Chen M, Gu J-l, et al. Cryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published cases. Int J Infect Dis. 2014;26:154–161. doi: 10.1016/j.ijid.2014.05.028
   PubMed Web of Science ®Google Scholar
• Vilchez R, Shapiro R, McCurry K, et al. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int. 2003;16:336–340. doi: 10.1111/j.1432-2277.2003.tb00309.x
   PubMed Web of Science ®Google Scholar
• Guimaraes LF, Halpern M, de Lemos AS, et al. Invasive fungal disease in renal transplant recipients at a Brazilian center: local epidemiology matters. Transplantation Proc. 2016;48:2306–2309. doi: 10.1016/j.transproceed.2016.06.019
   PubMed Web of Science ®Google Scholar
• Marques S, Carmo R, Ferreira I, et al. Cryptococcosis in renal transplant recipients: a single-center experience. Transplantation Proc. 2016;48:2289–2293. doi: 10.1016/j.transproceed.2016.06.006
   PubMed Web of Science ®Google Scholar
• Osawa R, Alexander BD, Forrest GN, et al. Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant. 2010;15:77–83.
   PubMed Web of Science ®Google Scholar
• Davis JA, Horn DL, Marr KA, et al. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS. Transplant Infect Dis. 2009;11:432–437. doi: 10.1111/j.1399-3062.2009.00424.x
   PubMed Web of Science ®Google Scholar
• Gassiep I, McDougall D, Douglas J, et al. Cryptococcal infections in solid organ transplant recipients over a 15-year period at a state transplant center. Transpl Infect Dis. 2017;19:e12639. doi: 10.1111/tid.12639
   Web of Science ®Google Scholar
• Kwon-Chung KJ, Bennett JE, Wickes BL, et al. The case for adopting the ‘species complex’ nomenclature for the etiologic agents of cryptococcosis. mSphere. 2017;2:pii: e00357-16. doi: 10.1128/mSphere.00357-16
   Web of Science ®Google Scholar
• Hagen F, Khayhan K, Theelen B, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol. 2015;78:16–48. doi: 10.1016/j.fgb.2015.02.009
   PubMed Web of Science ®Google Scholar
• Chen Y, Frazzitta AE, Litvintseva AP, et al. Next generation multilocus sequence typing (NGMLST) and the analytical software program MLSTEZ enable efficient, cost-effective, high-throughput, multilocus sequencing typing. Fungal Genet Biol. 2015;75:64–71. doi: 10.1016/j.fgb.2015.01.005
   PubMed Web of Science ®Google Scholar
• Munoz M, Camargo M, Ramirez JD. Estimating the intra-taxa diversity, population genetic structure, and evolutionary pathways of Cryptococcus neoformans and Cryptococcus gattii. Front Genet. 2018;9:148. doi: 10.3389/fgene.2018.00148
   PubMed Web of Science ®Google Scholar
• Firacative C, Duan S, Meyer W, et al. Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii. PloS One. 2014;9:e105076. doi: 10.1371/journal.pone.0105076
   PubMed Web of Science ®Google Scholar
• Beale MA, Sabiiti W, Robertson EJ, et al. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa. PLoS Negl Trop Dis. 2015;9:e0003847. doi: 10.1371/journal.pntd.0003847
   PubMed Web of Science ®Google Scholar
• Thompson GR, Albert N, Hodge G, et al. Phenotypic differences of cryptococcus molecular types and their implications for virulence in a drosophila model of infection. Infect Immun. 2014;82:3058–3065. doi: 10.1128/IAI.01805-14
   PubMed Web of Science ®Google Scholar
• Forrest GN, Bhalla P, DeBess EE, et al. Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases. Transplant Infect Dis. 2015;17:467–476. doi: 10.1111/tid.12370
   PubMed Web of Science ®Google Scholar
• Andrade-Silva LE, Ferreira-Paim K, Ferreira TB, et al. Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors. PloS One. 2018;13:e0193237. doi: 10.1371/journal.pone.0193237
   PubMed Web of Science ®Google Scholar
• Herkert PF, Meis JF, Lucca de Oliveira Salvador G, et al. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil. J Med Microbiol. 2018;67:560–569. doi: 10.1099/jmm.0.000698
   PubMed Web of Science ®Google Scholar
• Cicora F, Petroni J, Formosa P, et al. A rare case of Cryptococcus gattii pneumonia in a renal transplant patient. Transplant Infect Dis. 2015;17:463–466. doi: 10.1111/tid.12371
   PubMed Web of Science ®Google Scholar
• Chen SC, Slavin MA, Heath CH, et al. Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis. 2012;55:789–798. doi: 10.1093/cid/cis529
   PubMed Web of Science ®Google Scholar
• Ferreira-Paim K, Andrade-Silva L, Fonseca FM, et al. MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. grubii VNI isolates from HIV patients in Southeastern Brazil. PLoS Negl Trop Dis. 2017;11:e0005223. doi: 10.1371/journal.pntd.0005223
   PubMed Web of Science ®Google Scholar
• Souto AC, Bonfietti LX, Ferreira-Paim K, et al. Population genetic analysis reveals a high genetic diversity in the Brazilian Cryptococcus gattii VGII population and shifts the global origin from the Amazon rainforest to the semi-arid desert in the Northeast of Brazil. PLoS Negl Trop Dis. 2016;10:e0004885. doi: 10.1371/journal.pntd.0004885
   PubMed Web of Science ®Google Scholar
• Sun HY, Wagener MM, Singh N. Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis. 2009;48:1566–1576. doi: 10.1086/598936
   PubMed Web of Science ®Google Scholar
• Singh N, Alexander BD, Lortholary O, et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis. 2007;195:756–764. doi: 10.1086/511438
   PubMed Web of Science ®Google Scholar
• George IA, Spec A, Powderly WG, et al. Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), Non-HIV non-transplant, and solid organ transplant associated cryptococcosis: a population-based study. Clin Infect Dis. 2018;66:608–611. doi: 10.1093/cid/cix867
   PubMed Web of Science ®Google Scholar
• Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987;317:334–341. doi: 10.1056/NEJM198708063170602
   PubMed Web of Science ®Google Scholar
• Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PloS One. 2013;8:e60431. doi: 10.1371/journal.pone.0060431
   PubMed Web of Science ®Google Scholar
• Rhodes J, Desjardins CA, Sykes SM, et al. Tracing genetic exchange and biogeography of Cryptococcus neoformans var. grubii at the global population level. Genetics. 2017;207:327–346. doi: 10.1534/genetics.117.203836
   PubMed Web of Science ®Google Scholar
• Hagen F, Ceresini PC, Polacheck I, et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PloS One. 2013;8:e71148. doi: 10.1371/journal.pone.0071148
   PubMed Web of Science ®Google Scholar
• Engelthaler DM, Hicks ND, Gillece JD, et al. Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. MBio. 2014;5:e01464-14. doi: 10.1128/mBio.01464-14
   PubMed Web of Science ®Google Scholar
• Litvintseva AP, Thakur R, Vilgalys R, et al. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics. 2005;172:2223–2238. doi: 10.1534/genetics.105.046672
   PubMed Web of Science ®Google Scholar
• Barreto de Oliveira MT, Boekhout T, Theelen B, et al. Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol. 2004;42:1356–1359. doi: 10.1128/JCM.42.3.1356-1359.2004
   PubMed Web of Science ®Google Scholar
• Bovers M, Hagen F, Kuramae EE, et al. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res. 2006;6:599–607. doi: 10.1111/j.1567-1364.2006.00082.x
   PubMed Web of Science ®Google Scholar
• Ngamskulrungroj P, Gilgado F, Faganello J, et al. Genetic diversity of the cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PloS One. 2009;4:e5862. doi: 10.1371/journal.pone.0005862
   PubMed Web of Science ®Google Scholar
• Dou HT, Xu YC, Wang HZ, et al. Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the DiversiLab system. Eur J Clin Microbiol Infect Dis. 2015;34:753–762. doi: 10.1007/s10096-014-2289-2
   PubMed Web of Science ®Google Scholar
• Cogliati M, Prigitano A, Esposto MC, et al. Epidemiological trends of cryptococcosis in Italy: molecular typing and susceptibility pattern of Cryptococcus neoformans isolates collected during a 20-year period. Med Mycol. 2018;56(8):963–971.
   PubMed Web of Science ®Google Scholar
• Casadevall A, Freij JB, Hann-Soden C, et al. Continental drift and speciation of the Cryptococcus neoformans and Cryptococcus gattii species complexes. mSphere. 2017;2:pii: e00103-17.
   Web of Science ®Google Scholar
• Herkert PF, Hagen F, de Oliveira Salvador GL, et al. Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil. Eur J Clin Microbiol Infect Dis. 2016;35:1803–1810. doi: 10.1007/s10096-016-2731-8
   PubMed Web of Science ®Google Scholar
• Wiesner DL, Moskalenko O, Corcoran JM, et al. Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis. MBio. 2012;3: pii: e00196-12. doi: 10.1128/mBio.00196-12
   PubMed Web of Science ®Google Scholar
• Day JN, Qihui S, Thanh LT, et al. Comparative genomics of Cryptococcus neoformans var. grubii associated with meningitis in HIV infected and uninfected patients in Vietnam. PLoS Negl Trop Dis. 2017;11:e0005628. doi: 10.1371/journal.pntd.0005628
   PubMed Web of Science ®Google Scholar
• Tarai B, Tarai B, Kher V, et al. Early onset primary pulmonary cryptococcosis in a renal transplant patient. Indian J Med Microbiol. 2010;28:250–252. doi: 10.4103/0255-0857.66489
   PubMed Web of Science ®Google Scholar
• Trpkovic A, Pekmezovic M, Barac A, et al. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia. J Mycol Med. 2012;22:243–248. doi: 10.1016/j.mycmed.2012.06.002
   PubMed Web of Science ®Google Scholar
• Trilles L, Meyer W, Wanke B, et al. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol. 2012;50:328–332. doi: 10.3109/13693786.2011.602126
   PubMed Web of Science ®Google Scholar
• Andrade-Silva L, Ferreira-Paim K, Mora DJ, et al. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Med Mycol. 2013;51:635–640. doi: 10.3109/13693786.2012.761737
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Iqbal N, Bolden CB, et al. Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis. 2012;73:144–148. doi: 10.1016/j.diagmicrobio.2012.02.018
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Abdul M, Arpin M, et al. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother. 2006;50:2464–2470. doi: 10.1128/AAC.01520-05
   PubMed Web of Science ®Google Scholar
• Van Wyk M, Govender NP, Mitchell TG, et al. Multilocus sequence typing of serially collected isolates of cryptococcus from HIV-infected patients in South Africa. J Clin Microbiol. 2014;52:1921–1931. doi: 10.1128/JCM.03177-13
   PubMed Web of Science ®Google Scholar
• Rossi SA, Trevijano-Contador N, Scorzoni L, et al. Impact of resistance to fluconazole on virulence and morphological aspects of Cryptococcus neoformans and Cryptococcus gattii isolates. Front Microbiol. 2016;7:153.
   PubMed Web of Science ®Google Scholar
• Aller AI, Martin-Mazuelos E, Lozano F, et al. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother. 2000;44:1544–1548. doi: 10.1128/AAC.44.6.1544-1548.2000
   PubMed Web of Science ®Google Scholar
• Bicanic T, Harrison T, Niepieklo A, et al. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis. 2006;43:1069–1073. doi: 10.1086/507895
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin-Pelissier S, Launay O, et al. Determinants of disease presentation and outcome during cryptococcosis: The CryptoA/D study. PLoS Med. 2007;4:e21. doi: 10.1371/journal.pmed.0040021
   PubMed Web of Science ®Google Scholar
• Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–1874. doi: 10.1093/molbev/msw054
   PubMed Web of Science ®Google Scholar
• Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–2729. doi: 10.1093/molbev/mst197
   PubMed Web of Science ®Google Scholar
• Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25:1451–1452. doi: 10.1093/bioinformatics/btp187
   PubMed Web of Science ®Google Scholar
• Tanaka R, Taguchi H, Takeo K, et al. Determination of ploidy in Cryptococcus neoformans by flow cytometry. J Med Vet Mycol. 1996;34:299–301. doi: 10.1080/02681219680000521
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard – 3rd ed. CLSI document M27-A3. Wayne (PA): Clinical and Laboratory Standards Institute; 2008. ISBN 1-56238-666-2.
   Google Scholar
• Espinel-Ingroff A, Aller AI, Canton E, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother. 2012;56:5898–5906. doi: 10.1128/AAC.01115-12
   PubMed Web of Science ®Google Scholar